Target intelligence / Profile preview

Injured renal microenvironment

Molecular classification
Other
01

Overview

The injured renal microenvironment refers to the complex spatial and cellular context within the kidney that arises following tissue injury. This microenvironment involves dramatic changes in the composition and activity of resident and infiltrating cells, alterations in extracellular matrix, and activation of various signaling pathways. Key participants include injured tubular epithelial cells, fibroblasts, endothelial cells, and diverse immune cells (e.g., macrophages, T cells, dendritic cells), all orchestrating the response to injury. Molecular signals in this setting drive inflammation, recruit immune cells, mediate fibrosis, and determine the balance between reparative and pathological tissue remodeling. Specific ligand-receptor interactions, such as CLCF1-CRLF1 between injured cells and fibroblasts, promote fibrosis and chronic kidney disease risk. The spatial heterogeneity and dynamic interplay among cells within the injured renal microenvironment complicate targeted therapeutic intervention, but also present opportunities for spatially focused therapies and biomarker-guided approaches.

Other names
injured kidney microenvironmentrenal injury microenvironmentdamaged renal microenvironmentinjured renal milieu
02

Mechanism of action

No single drug mechanism; mechanisms would include modulation of immune response, inhibition of fibrosis, or promotion of tubular repair in the context of the injured microenvironment.

03

Biological functions

Inflammatory responseTissue repairFibrosisImmune cell recruitmentCell-cell signalingCell proliferationCell death
04

Disease associations

Acute kidney injuryChronic kidney diseaseInflammationFibrosis
05

Safety considerations

Therapeutic interventions in the injured renal microenvironment risk exacerbating inflammation, inducing off-target immune suppression, or impairing regenerative processesDifficulty in precisely targeting defined cell populations or pathways due to the microenvironment’s heterogeneity and dynamic nature
06

Biomarkers

KIM-1 (Kidney injury molecule-1)LCN2 (Lipocalin-2/NGAL)HBEGFSERPINE2APBB1IPTRIP13ATF3NCAPHTIMPs (Tissue inhibitors of metalloproteinases)Fibroblast markers (e.g., Crlf1, Timp1, Npr3)

Beyond the preview

Go deeper on Injured renal microenvironment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Injured renal microenvironment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call